Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Contineum Therapeutics Appoints John Healy As General Counsel & Corporate Secretary

PUBLIC · CTNMJun 03, 2024•about 2 years ago

Position

Corporate Secretary

Company

Contineum Therapeutics

John Healy
San DiegoManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Contineum Therapeutics, Inc. announced the appointment of John Healy as General Counsel & Corporate Secretary. Carmine Stengone, Chief Executive Officer of Contineum, expressed excitement for John joining the team and highlighted his extensive experience in the life sciences industry

Company Information

Company

Contineum Therapeutics

Location

San Diego, California, United States

About

Contineum Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications. The company has a pipeline of internally-developed programs to address multiple NI&I disorders, primarily targeting biological pathways associated with specific clinical impairments. Contineum is headquartered in San Diego, CA.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Contineum Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.